Androgen receptors in experimentally induced colon carcinogenesis.
Sex hormones may play a role in colonic carcinogenesis, as evidenced by epidemiologic and experimental data showing different tumor rates in males and females. We investigated the effects of hormonal manipulation on tumor development and on androgen receptor binding in both colonic wall and experimentally induced tumors in male rats. Five of six groups, each with 40 animals, were given 10 weekly s.c. injections of azoxymethane (AOM), 7.5 mg/kg body weight. Group-I served as normal controls. Group-II received AOM only. Group-III was castrated 2 weeks prior to carcinogen treatment. Group-IV was castrated similarly and then hormone substituted with testosterone propionate. Group-V was chemically castrated with the anti androgen cyproterone acetate. Group-VI was castrated and given hormone vehicle. Scatchard analysis for androgen receptors in cytosol from normal colonic wall and tumor was performed with 3H-methyltrienolone as the ligand. Androgens were found to have an inhibitory effect on carcinogenesis: chemical castration increased colonic tumor development (P less than 0.05 for multiplicity), and testosterone administration produced a borderline statistically significant reduction in tumor incidence in surgically castrated rats (P less than 0.053), particularly in the right colon. Specific binding sites for androgen with high affinity and low capacity were found in the colonic wall of all groups. Receptor density was not altered by AOM administration, but increased after surgical castration. Receptor density was markedly lower in tumors than in normal colonic wall. Receptor binding sites in tumors were not altered by the various hormonal manipulations. Our study demonstrated that although cytoplasmic androgen receptors are present in colonic wall and in experimental tumors, AOM-induced colonic carcinogenesis appears to be only mildly affected by manipulation of androgens.
D000818:Animals; D001397:Azoxymethane / Q000494:pharmacology; D001665:Binding Sites; D001835:Body Weight / Q000187:drug effects; D003106:Colon / Q000378:metabolism; D003110:Colonic Neoplasms / Q000032:analysis* / Q000139:chemically induced; D003534:Cyproterone / Q000031:analogs & derivatives / Q000494:pharmacology; D017373:Cyproterone Acetate; D003600:Cytosol / Q000378:metabolism; D004963:Estrenes / Q000378:metabolism; D007700:Kinetics; D008297:Male; D015741:Metribolone; D009919:Orchiectomy; D051381:Rats; D011919:Rats, Inbred Strains; D011944:Receptors, Androgen / Q000032:analysis*; D012004:Rectal Neoplasms / Q000032:analysis; D013739:Testosterone / Q000494:pharmacology
D004963:Estrenes; D011944:Receptors, Androgen; D015741:Metribolone; D013739:Testosterone; D017373:Cyproterone Acetate; D003534:Cyproterone; D001397:Azoxymethane